Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in clindamycin-treated mice

Antimicrob Agents Chemother. 2006 Nov;50(11):3905-7. doi: 10.1128/AAC.00522-06. Epub 2006 Aug 28.

Abstract

Proton pump inhibitor treatment of clindamycin-treated mice elevated the gastric pH and facilitated the establishment of colonization of the large intestine by vancomycin-resistant Enterococcus spp. (75 to 80%, versus 20 to 25% for saline-treated controls) and Klebsiella pneumoniae (90%, versus 30% for saline-treated controls). These findings demonstrate a mechanism by which proton pump inhibitor therapy could contribute to the dissemination of nosocomial pathogens.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Clindamycin / pharmacology*
  • Enterococcus / drug effects
  • Enterococcus / growth & development*
  • Female
  • Gastric Acid / metabolism*
  • Intestine, Large / drug effects
  • Intestine, Large / microbiology*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / growth & development*
  • Mice
  • Proton Pump Inhibitors*
  • Vancomycin Resistance / physiology*

Substances

  • Anti-Bacterial Agents
  • Proton Pump Inhibitors
  • Clindamycin